400-859-2883
Current Location:Home > Product Center> Product catalog> Intermediates

Intermediates

Methyl 6-bromo-3-oxo-3,4-dihydropyrazine-2-carboxylate

Methyl 6-bromo-3-oxo-3,4-dihydropyrazine-2-carboxylate
User Evaluation Collection Products
Synonyms
6-Bromo-3-hydroxy-pyrazine-2-carboxylic acid methyl ester
Catalog ID
100466
CAS NO.
21874-61-3
Purity
95%
MDL Number
MFCD28405860
EINECS
Molecular formula
C6H5BrN2O3
Molecular weight
233.02
Huateng Pharmaceutical, a global supplier of pharmaceutical intermediates, offers Favipiravir intermediates Methyl 6-bromo-3-oxo-3,4-dihydropyrazine-2-carboxylate (CAS NO. 21874-61-3) for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation

Favipiravir, also known as T-705 or Avigan, is an antiviral drug being developed by Toyama Chemical (Fujifilm group) of Japan with activity against many RNA viruses. In February 2020 Favipiravir was being studied in China for experimental treatment of the emergent COVID-19 (novel coronavirus) disease.

Find More ​Favipiravir Intermediates>>>

I want to comment